Angelo Piermattei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angelo Piermattei has a total of 383 co-authors. Here are the top co-authors by number of shared publications:
- Luigi Azario
Università Cattolica del Sacro Cuore
58 shared publications - Andrea Fidanzio
Istituto di Fisica, Universita Cattolica del Sacro Cuore, Rome, Italy
49 shared publications - Alessio Giuseppe Morganti
Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40126 Bologna, Italy
45 shared publications - Gabriella Macchia
Radiation Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, 86100 Campobasso, Italy
42 shared publications Savino Cilla
Istituto Nazionale di Fisica Nucleare (INFN)
31 shared publications- Vincenzo Valentini
Università Cattolica del Sacro Cuore, Rome, Italy, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, Rome Italy, Italy
25 shared publications
Latest Publications
- Open Access
- 9 July 2016
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 15 (4) , 535-545
Step-and-Shoot IMRT by Siemens Beams
Purpose: This work reports the extension of a semiempirical method based on the correlation ratios to convert electronic portal imaging devices transit signals into in vivo doses for the step-and-shoot intensity-modulated radiotherapy Siemens beams. The dose reconstructed at the isocenter point Diso, compared to the planned dose, Diso,TPS, and a γ-analysis between 2-dimensional electronic portal imaging device images obtained day to day, seems to supply a practical method to verify the beam delivery reproducibility. Method: The electronic portal imaging device images were obtained by the superposition of many segment fields, and the algorithm for the Diso reconstruction for intensity-modulated radiotherapy step and shoot was formulated using a set of simulated intensity-modulated radiotherapy beams. Moreover, the in vivo dose-dedicated software was integrated with the record and verify system of the centers. Results: Three radiotherapy centers applied the in vivo dose procedure at 30 clinical intensity-modulated radiotherapy treatments, each one obtained with 5 or 7 beams, and planned for patients undergoing radiotherapy for prostatic tumors. Each treatment beam was checked 5 times, obtaining 900 tests of the ratios R = Diso/Diso,TPS. The average R value was equal to 1.002 ± 0.056 (2 standard deviation), while the mean R value for each patient was well within 5%, once the causes of errors were removed. The γ-analysis of the electronic portal imaging device images, with 3% 3 mm acceptance criteria, showed 90% of the tests with Pγ < 1 ≥ 95% and γmean ≤ 0.5. The off-tolerance tests were found due to incorrect setup or presence of morphological changes. This preliminary experience shows the great utility of obtaining the in vivo dose results in quasi real time and close to the linac, where the radiotherapy staff may immediately spot possible causes of errors. The in vivo dose procedure presented here is one of the objectives of a project, for the development of practical in vivo dose procedures, financially supported by the Istituto Nazionale di Fisica Nucleare.
- 9 July 2016
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 15 (4) , 535-545
Open AccessStep-and-Shoot IMRT by Siemens Beams
Purpose: This work reports the extension of a semiempirical method based on the correlation ratios to convert electronic portal imaging devices transit signals into in vivo doses for the step-and-shoot intensity-modulated radiotherapy Siemens beams. The dose reconstructed at the isocenter point Diso, compared to the planned dose, Diso,TPS, and a γ-analysis between 2-dimensional electronic portal imaging device images obtained day to day, seems to supply a practical method to verify the beam delivery reproducibility. Method: The electronic portal imaging device images were obtained by the superposition of many segment fields, and the algorithm for the Diso reconstruction for intensity-modulated radiotherapy step and shoot was formulated using a set of simulated intensity-modulated radiotherapy beams. Moreover, the in vivo dose-dedicated software was integrated with the record and verify system of the centers. Results: Three radiotherapy centers applied the in vivo dose procedure at 30 clinical intensity-modulated radiotherapy treatments, each one obtained with 5 or 7 beams, and planned for patients undergoing radiotherapy for prostatic tumors. Each treatment beam was checked 5 times, obtaining 900 tests of the ratios R = Diso/Diso,TPS. The average R value was equal to 1.002 ± 0.056 (2 standard deviation), while the mean R value for each patient was well within 5%, once the causes of errors were removed. The γ-analysis of the electronic portal imaging device images, with 3% 3 mm acceptance criteria, showed 90% of the tests with Pγ < 1 ≥ 95% and γmean ≤ 0.5. The off-tolerance tests were found due to incorrect setup or presence of morphological changes. This preliminary experience shows the great utility of obtaining the in vivo dose results in quasi real time and close to the linac, where the radiotherapy staff may immediately spot possible causes of errors. The in vivo dose procedure presented here is one of the objectives of a project, for the development of practical in vivo dose procedures, financially supported by the Istituto Nazionale di Fisica Nucleare.
- 1 February 2016
- Published by Elsevier in Physica Medica
- Vol. 32, 32-33
Clinical implications after a change in the dose calculation algorithm in vmat treatments of nasopharyngeal tumors
- 1 February 2016
- Published by Elsevier in Physica Medica
- Vol. 32, 32-33
Clinical implications after a change in the dose calculation algorithm in vmat treatments of nasopharyngeal tumors
- 1 February 2016
- Published by Elsevier in Physica Medica
- Vol. 32, 14
EPID-based in-vivo dosimetry for VMAT treatment dose verification: Initial clinical experience
- 1 February 2016
- Published by Elsevier in Physica Medica
- Vol. 32, 14
EPID-based in-vivo dosimetry for VMAT treatment dose verification: Initial clinical experience
- Open Access
- 1 April 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115, S852
EP-1559: Initial clinical experience with EPID-based in-vivo dosimetry for VMAT treatment verification
- 1 April 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115, S852
Open AccessEP-1559: Initial clinical experience with EPID-based in-vivo dosimetry for VMAT treatment verification
- 31 March 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (8) , N141-N150
Routine EPIDin-vivodosimetry in a reference point for conformal radiotherapy treatments
In-vivo dosimetry (IVD) in external beam radiotherapy is used to detect major clinically relevant differences between planned and delivered dose. Moreover, a detailed analysis of its results, when routinely reported and discussed by the radiotherapy staff, can limit the likelihood of error transmission to many treatments. A first experience of routine EPID-based IVD in a reference point has been performed in our department for 3D-CRT treatments over a three-year period. More than 14 000 images were acquired and 1287 treatment plans were verified. The IVD checks were obtained three times in the first week and then weekly. Tolerance levels of ±5% for pelvic–abdomen, head–neck and breast irradiations and ±6% for lung treatments were adopted for the in-vivo measured dose per fraction. A statistical analysis of the IVD results was performed grouping the data by: anatomical regions, treatment units, open and wedged fields and gantry angles. About 10% of the checked doses per fraction showed dosimetric discrepancies out of the tolerance levels. The causes of the discrepancies were 70% delivery or planning errors, 20% morphological changes and 10% procedural limitations. 41 cases (3.2%) have required special investigations because their in-vivo doses per fraction, averaged over the first three sessions, were out of the tolerance levels and in 19 cases (1.5%) the deviations gave rise to an intervention. Statistically significant differences of average variations between planned and delivered doses were observed for: (i) 30° wedged 10 MV fields with respect to those of other wedged or open 10 MV fields delivered by two linacs, due to the incorrect TPS implementation of that wedge transmission factor; (ii) anterior–posterior and posterior–anterior beams with respect to the other gantry orientations for one linac, due to the beam attenuation introduced by the treatment couch; (iii) lateral fields with respect to medial fields of breast irradiations for all linacs, due to small systematic set-up variations. The analysis of our data shows a substantial homogeneity of the IVD results for all the considered body regions and treatment units. However, the observed discrepancies have supplied indications for taking further steps in the optimization process and in some cases to adopt an adaptive approach.
- 31 March 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (8) , N141-N150
Routine EPIDin-vivodosimetry in a reference point for conformal radiotherapy treatments
In-vivo dosimetry (IVD) in external beam radiotherapy is used to detect major clinically relevant differences between planned and delivered dose. Moreover, a detailed analysis of its results, when routinely reported and discussed by the radiotherapy staff, can limit the likelihood of error transmission to many treatments. A first experience of routine EPID-based IVD in a reference point has been performed in our department for 3D-CRT treatments over a three-year period. More than 14 000 images were acquired and 1287 treatment plans were verified. The IVD checks were obtained three times in the first week and then weekly. Tolerance levels of ±5% for pelvic–abdomen, head–neck and breast irradiations and ±6% for lung treatments were adopted for the in-vivo measured dose per fraction. A statistical analysis of the IVD results was performed grouping the data by: anatomical regions, treatment units, open and wedged fields and gantry angles. About 10% of the checked doses per fraction showed dosimetric discrepancies out of the tolerance levels. The causes of the discrepancies were 70% delivery or planning errors, 20% morphological changes and 10% procedural limitations. 41 cases (3.2%) have required special investigations because their in-vivo doses per fraction, averaged over the first three sessions, were out of the tolerance levels and in 19 cases (1.5%) the deviations gave rise to an intervention. Statistically significant differences of average variations between planned and delivered doses were observed for: (i) 30° wedged 10 MV fields with respect to those of other wedged or open 10 MV fields delivered by two linacs, due to the incorrect TPS implementation of that wedge transmission factor; (ii) anterior–posterior and posterior–anterior beams with respect to the other gantry orientations for one linac, due to the beam attenuation introduced by the treatment couch; (iii) lateral fields with respect to medial fields of breast irradiations for all linacs, due to small systematic set-up variations. The analysis of our data shows a substantial homogeneity of the IVD results for all the considered body regions and treatment units. However, the observed discrepancies have supplied indications for taking further steps in the optimization process and in some cases to adopt an adaptive approach.
- 1 December 2014
- Published by Elsevier in Clinical Oncology
- Vol. 26 (12) , 748-756
Stereotactic Radiosurgery (SRS) with Volumetric Modulated Arc Therapy (VMAT): Interim Results of a Multi-arm Phase I Trial (DESTROY-2)
- 1 December 2014
- Published by Elsevier in Clinical Oncology
- Vol. 26 (12) , 748-756
Stereotactic Radiosurgery (SRS) with Volumetric Modulated Arc Therapy (VMAT): Interim Results of a Multi-arm Phase I Trial (DESTROY-2)
- 1 June 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (4) , 473-481
Clinical implications of different calculation algorithms in breast radiotherapy: A comparison between pencil beam and collapsed cone convolution
- 1 June 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (4) , 473-481
Clinical implications of different calculation algorithms in breast radiotherapy: A comparison between pencil beam and collapsed cone convolution
- 1 June 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (4) , 419-426
An in-vivo dosimetry procedure for Elekta step and shoot IMRT
- 1 June 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (4) , 419-426
An in-vivo dosimetry procedure for Elekta step and shoot IMRT
- 20 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part1) , 062103
Quasi real time in vivo dosimetry for VMAT
Purpose: Results about the feasibility of a method for quasi real timein vivo dosimetry (IVD) at the isocenter point for volumetric modulated arc therapy (VMAT) are here reported. The method is based on correlations between the EPID signal and the dose on the beam central axis. Moreover, the γ‐analysis of EPID images was adopted to verify off‐axis reproducibility of fractionated plan delivery. Methods: An algorithm to reconstructin vivo the isocenter dose, Diso, for RapidArc treatments has been developed. 20 VMAT plans, optimized with two opposite arcs, for prostate, pancreas, and head treatments have been delivered by a Varian linac both to a conic PMMA phantom with elliptical section and to patients. The ratios R between reconstructed Diso and the planned doses were determined for phantom and patient irradiations adopting an acceptance criterion of ±5%. In total, 40 phantom checks and 400 patient checks were analyzed. Moreover, 3% and 3 mm criteria were adopted for portal image γ‐analysis to assess patient irradiation reproducibility. Results: The average ratio R, between reconstructed and planned doses for the PMMA phantom irradiations was equal to 1.007 ± 0.024. When the IVD method was applied to the 20 patients, the average R ratio was equal to 1.003 ± 0.017 and 96% of the tests were within the acceptance criteria. The portal image γ‐analysis supplied 88% of the tests within the pass rates γmean ≤ 0.4 and Pγ ≥ 98%. All the warnings were understood comparing the CT and the cone beam CT images and in one case a patient's setup error was detected and corrected for the successive fractions. Conclusions: This preliminary experience suggests that the method is able to detect dosimetric errors in quasi real time at the end of the therapy session. The authors intend to extend this procedure to other pathologies with the integration of in‐room imaging verification by cone beam CT.
- 20 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part1) , 062103
Quasi real time in vivo dosimetry for VMAT
Purpose: Results about the feasibility of a method for quasi real timein vivo dosimetry (IVD) at the isocenter point for volumetric modulated arc therapy (VMAT) are here reported. The method is based on correlations between the EPID signal and the dose on the beam central axis. Moreover, the γ‐analysis of EPID images was adopted to verify off‐axis reproducibility of fractionated plan delivery. Methods: An algorithm to reconstructin vivo the isocenter dose, Diso, for RapidArc treatments has been developed. 20 VMAT plans, optimized with two opposite arcs, for prostate, pancreas, and head treatments have been delivered by a Varian linac both to a conic PMMA phantom with elliptical section and to patients. The ratios R between reconstructed Diso and the planned doses were determined for phantom and patient irradiations adopting an acceptance criterion of ±5%. In total, 40 phantom checks and 400 patient checks were analyzed. Moreover, 3% and 3 mm criteria were adopted for portal image γ‐analysis to assess patient irradiation reproducibility. Results: The average ratio R, between reconstructed and planned doses for the PMMA phantom irradiations was equal to 1.007 ± 0.024. When the IVD method was applied to the 20 patients, the average R ratio was equal to 1.003 ± 0.017 and 96% of the tests were within the acceptance criteria. The portal image γ‐analysis supplied 88% of the tests within the pass rates γmean ≤ 0.4 and Pγ ≥ 98%. All the warnings were understood comparing the CT and the cone beam CT images and in one case a patient's setup error was detected and corrected for the successive fractions. Conclusions: This preliminary experience suggests that the method is able to detect dosimetric errors in quasi real time at the end of the therapy session. The authors intend to extend this procedure to other pathologies with the integration of in‐room imaging verification by cone beam CT.